Polyol pathway activation and glutathione redox status in non-insulin- dependent diabetic patients

Metabolism: Clinical and Experimental

Volumn 46, Issue 10, 1997, Pages 1194-1198

  Bravi, Maria C ^a   Pietrangeli, Paola ^a   Laurenti, Oriana ^a   Basili, Stefania ^a   Cassone Faldetta, Maria ^a   Ferri, Claudio ^a   De Mattia, Giancarlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; GLUTATHIONE DISULFIDE; POLYOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TOLRESTAT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME INHIBITION; ERYTHROCYTE LEVEL; FEMALE; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030854361     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90216-X     Document Type: Article

References (29)

1. Gabbay KH: The sorbitol pathway and the complications of diabetes. N Engl J Med 288:231-236, 1973
2. Kinoshita JH, Nishimura C: The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 4:323-337, 1988
3. Kador PF: The role of aldose-reductase in the development of diabetic complications. Med Res Rev 3:325-328, 1988
4. Hers HG: L'aldose-reductase. Biochim Biophys Acta 37:120-126, 1960
5. Kuck J: The formation of fructose in the ocular lens. Arch Ophthalmol 65:840-846, 1961
6. Varma SD, Kinoshita JH: Sorbitol pathway in diabetic and galactosemic rat lens. Biochim Biophys Acta 338:632-640, 1974
7. Morrison AD, Clements RS, Travis SB, et al: Glucose utilization by the polyol pathway in human erythrocytes. Biochem Biophys Res Commun 40:199-205, 1970
8. Gabbay KH: Role of sorbitol pathway in neuropathy. Adv Metab Disord 2:417-424, 1973 (suppl)
9. Chylack LT, Kinoshita JH: A biochemical evaluation of a cataract induced in high glucose medium. Invest Ophthalmol 8:401-412, 1969
10. Travis SF, Morrison AD, Clements RS, et al: Metabolic alterations in the human erythrocytes produced by increases in glucose concentrations. J Clin Invest 50:2104-2112, 1971
11. Williamson JR, Cang K, Frangos M, et al: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
12. Barnett PA, Gonzalez RG, Chylack LT: The effects of oxidation on sorbitol pathway kinetics. Diabetes 35:426-432, 1986
13. Fujii S, Dale GL, Beutler E: Glutathione-dependent protection against oxidative damage of the human red cell membrane. Blood 63:1096-1101, 1984
14. Murakami K, Kondo T, Ohtsuka Y, et al: Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 38:753-758, 1989
15. De Mattia G, Laurenti O, Bravi C, et al: Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients. Metabolism 43:965-968, 1994
16. Clements RS Jr, Morrison AD, Winegrad AI: Polyol pathway in aorta: Regulation by hormones. Science 166:1007-1008, 1969
17. Anderson ME: Determination of glutathione and glutathione disulfide in biological samples, in Methods in Enzymology, vol 113. New York, NY, Academic, 1987, pp 548-557
18. Griffith OW: Determination of glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106:207-212, 1980
19. Klingenberg M: Nicotinamide-adenine dinucleotides and dinucleotide phosphates, in Bergmeyer HU (ed): Methods of Enzymatic Analysis, vol 3 (ed 3). Weinheim, Germany, 1985, pp 251-284
20. Beutler E, Blume KG, Kaplan JC, et al: International Committee for Standardization in Haematology: Recommended methods for red cell enzyme analysis. Br J Haematol 35:331-340, 1977
21. Armitage P, Berry G: Chapter 7, Section 6, Chapter 13, Sections 3 and 4, in Statistical Methods in Medical Research (ed 2). Oxford, UK, Blackwell Scientific, 1990, pp 200-215
22. Lehninger AL, Nelson DL, Cox MM: Chapter 5, in Principles of Biochemistry (ed 2). New York, NY, Worth, 1993
23. Kirkman NH, Gaetani GD, Clemons HE, et al: Red cell NADP and NADPH in glucose-6-phosphate dehydrogenase deficiency. J Clin Invest 55:875-878, 1975
24. Costagliola C: Oxidative state of glutathione in red blood cells and plasma of diabetic patients: In vivo and in vitro studies. Clin Physiol Biochem 8:204-210, 1990
25. Lou MF, Dickerson JE, Garadi R, et al: Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res 46:517-530, 1988
26. Bono A, Caimi G, Catania A, et al: Red cell peroxide metabolism in diabetes mellitus. Horm Metab Res 19:264-266, 1987
27. Jain SK, McVie R: Effect of glycemic control, race (white versus black) and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 43:306-309, 1994
28. Yoshida K, Hirokawa J, Tagami S, et al: Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: Regulation of glutathione synthesis and efflux. Diabetologia 38:201-210, 1995
29. Gonzalez AM, Sochor M, McLean P: The effect of an aldose reductase inhibitor (sorbinil) on the level of metabolites in lenses of diabetic rats. Diabetes 32:482-485, 1983